Latest oppositions filed by Amgen

This table presents recent patent oppositions filed by Amgen against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3384049Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VegfREGENERON PHARMACEUTICALS, INC.Apr 22, 2024
EP3536712Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)REGENERON PHARMACEUTICALS, INC.Feb 29, 2024
EP3345607Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI-MAB LLCJul 26, 2023
EP2894165Methods And Compositions For Treating Complement-Associated DisordersALEXION PHARMACEUTICALS, INC.May 17, 2023
EP3716992Use Of A Vegf Antagonist To Treat Angiogenic Eye DisordersREGENERON PHARMACEUTICALS, INC.May 10, 2023
EP3230316Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization LesionBAYER HEALTHCARE LLCOct 5, 2022
EP2825558Combination Therapy For The Treatment Of Ovarian CancerF. HOFFMANN-LA ROCHE AGFeb 17, 2020
EP2756004Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)REGENERON PHARMACEUTICALS, INC.Dec 27, 2019
EP3038647Combination Therapy For The Treatment Of GlioblastomaF. HOFFMANN-LA ROCHE AGDec 23, 2019
EP3145487Liquid Pharmaceutical CompositionARES TRADING SADec 20, 2018

The following table provides an overview of the latest patents of Amgen that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP4209499Aug 7, 2024Charged Depth Filtration Of Antigen-Binding Proteins1
EP3819007Jul 10, 2024Dosing Regimen For Anti-Bcma Agents4
EP2637670Mar 13, 2024Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains4
EP4058148Mar 13, 2024Dosing Regimen For Anti-Bcma Agents4
EP3615066Dec 27, 2023Formulations Of Human Anti-Rankl Antibodies, And Methods Of Using The Same1
EP2301961Dec 13, 2023Sclerostin Epitopes4
EP2445924Dec 13, 2023Capture Purification Processes For Proteins Expressed In A Non-Mammalian System2
EP3334747Sep 27, 2023Charged Depth Filtration Of Antigen-Binding Proteins7
EP3531133Aug 23, 2023Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients2
EP3665706Aug 2, 2023Graphical User Interface For Personalized Prediction Modeling1